Microscopic Warriors - Immunomodulatory and Anticancer Properties of Fungi
DOI:
https://doi.org/10.53350/pjmhs02026201.2Keywords:
mushrooms; fungus; prevention; risk; neoplasms; cancer.Abstract
Background: Fungi, comprising a vast and diverse kingdom, are increasingly recognized for their bioactive compounds with potential health benefits, including anticancer properties. Mushrooms, rich in polysaccharides, proteins, vitamins, and trace elements, have traditionally been used for disease prevention and treatment, notably cancer.
Materials and Methods: A thorough review of the literature was carried out using the PubMed and Google Scholar databases, with search terms focusing on mushrooms and different types of cancer. The analysis included observational studies, meta-analyses, and experimental research that examined the relationship between mushroom consumption and cancer risk or progression.
Aim of the Study: to systematically review existing literature on the relationship between mushroom intake and cancer risk, focusing on breast, prostate, gastric, colorectal, and lung cancers, and to discuss the immunomodulatory and therapeutic effects of fungal bioactive compounds.
Results: Evidence indicates a notable negative correlation was observed between mushroom intake and the risk of specific types of cancer particularly breast and prostate cancer, with some studies highlighting immunomodulatory effects of β-glucans and other fungal compounds. Mushroom consumption is linked to lower overall mortality and reduced risk of breast cancer, especially in populations of Asian origin and postmenopausal females. While results are more consistent in Asian cohorts, data from Western countries are inconclusive, suggesting the need for further research. Mushroom extracts such as PSK have shown promise as adjunctive therapies in gastric and colorectal cancers.
Conclusion: Overall, mushrooms represent a valuable dietary component with potential cancer-preventive and supportive therapeutic roles, warranting further clinical investigation.
References
Cheek M, Nic Lughadha E, Kirk P, Lindon H, Carretero J, Looney B, i in. New scientific discoveries: Plants and fungi. Plants People Planet. 2020;2(5):371–88.
Królestwo grzybów na przełomie tysiącleci [Internet]. [cytowane 8 styczeń 2025]. Dostępne na: http://maxbot.botany.pl/cgi-bin/pubs/data/article_pdf?id=2311
Alves MJ, Ferreira ICFR, Dias J, Teixeira V, Martins A, Pintado M. A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds. Planta Med. listopad 2012;78(16):1707–18.
Valverde ME, Hernández-Pérez T, Paredes-López O. Edible mushrooms: improving human health and promoting quality life. Int J Microbiol. 2015;2015:376387.
Mattila P, Könkö K, Eurola M, Pihlava JM, Astola J, Vahteristo L, i in. Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. J Agric Food Chem. maj 2001;49(5):2343–8.
Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. czerwiec 2005;67(4):453–68.
Patel S, Goyal A. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech. marzec 2012;2(1):1–15.
Li Q, Niu Y, Xing P, Wang C. Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair. Chin Med. 6 luty 2018;13(1):7.
Zong A, Cao H, Wang F. Anticancer polysaccharides from natural resources: A review of recent research. Carbohydr Polym. 6 listopad 2012;90(4):1395–410.
Kiddane AT, Kim GD. Anticancer and Immunomodulatory Effects of Polysaccharides. Nutr Cancer. 2021;73(11–12):2219–31.
Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol. 1 styczeń 2007;18(1):4–19.
Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E. Effects of beta-glucans on the immune system. Med Kaunas Lith. 2007;43(8):597–606.
Kopczynski K. Immunomodulating and anticancer properties of fungi. Acta Mycol [Internet]. 2012 [cytowane 9 styczeń 2025];47(1). Dostępne na: https://bibliotekanauki.pl/articles/67209
Singh RS, Bhari R, Kaur HP. Mushroom lectins: current status and future perspectives. Crit Rev Biotechnol. czerwiec 2010;30(2):99–126.
Xu X, Yan H, Chen J, Zhang X. Bioactive proteins from mushrooms. Biotechnol Adv. 2011;29(6):667–74.
Liu Y, Bastiaan-Net S, Wichers HJ. Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins. Front Nutr. 2020;7:132.
Kuan YC, Wu YJ, Hung CL, Sheu F. Trametes versicolor protein YZP activates regulatory B lymphocytes - gene identification through de novo assembly and function analysis in a murine acute colitis model. PloS One. 2013;8(9):e72422.
Diling C, Chaoqun Z, Jian Y, Jian L, Jiyan S, Yizhen X, i in. Immunomodulatory Activities of a Fungal Protein Extracted from Hericium erinaceus through Regulating the Gut Microbiota. Front Immunol. 2017;8:666.
Ferreira ICFR, Barros L, Abreu RMV. Antioxidants in wild mushrooms. Curr Med Chem. 2009;16(12):1543–60.
Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, i in. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med. 1 styczeń 2004;36(1):1–15.
Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2014;e478-486.
Falandysz J. Selenium in edible mushrooms. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev. 2008;26(3):256–99.
Ba DM, Ssentongo P, Beelman RB, Muscat J, Gao X, Richie JP. Higher Mushroom Consumption Is Associated with Lower Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Adv Nutr Bethesda Md. 1 październik 2021;12(5):1691–704.
Gariboldi MB, Marras E, Ferrario N, Vivona V, Prini P, Vignati F, i in. Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer. Int J Mol Sci. 14 czerwiec 2023;24(12):10120.
Li J, Zou L, Chen W, Zhu B, Shen N, Ke J, i in. Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies. PloS One. 2014;9(4):e93437.
Hong SA, Kim K, Nam SJ, Kong G, Kim MK. A case–control study on the dietary intake of mushrooms and breast cancer risk among Korean women. Int J Cancer. 2008;122(4):919–23.
Shin A, Kim J, Lim SY, Kim G, Sung MK, Lee ES, i in. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer. 2010;62(4):476–83.
Lee DH, Yang M, Keum N, Giovannucci EL, Sun Q, Chavarro JE. Mushroom Consumption and Risk of Total and Site-Specific Cancer in Two Large U.S. Prospective Cohorts. Cancer Prev Res Phila Pa. sierpień 2019;12(8):517–26.
Zhang S, Sugawara Y, Chen S, Beelman RB, Tsuduki T, Tomata Y, i in. Mushroom consumption and incident risk of prostate cancer in Japan: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study. Int J Cancer. 2020;146(10):2712–20.
Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo. J Nutr Biochem. październik 2009;20(10):753–64.
Dan A, Swain R, Belonce S, Jacobs RJ. Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review. Cureus. kwiecień 2023;15(4):e37574.
Hsu JT, Hsu CS, Le PH, Chen TC, Chou WC, Lin CY, i in. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1. J Surg Res. 1 maj 2017;211:30–8.
Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, i in. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Exp Ther Med. czerwiec 2012;3(6):925–30.
Tanaka H, Muguruma K, Ohira M, Kubo N, Yamashita Y, Maeda K, i in. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer Res. sierpień 2012;32(8):3427–33.
Miyake Y, Nishimura J, Kato T, Ikeda M, Tsujie M, Hata T, i in. Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG). Surg Today. styczeń 2018;48(1):66–72.
Eliza WLY, Fai CK, Chung LP. Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Pat Inflamm Allergy Drug Discov. styczeń 2012;6(1):78–87.
Fritz H, Kennedy DA, Ishii M, Fergusson D, Fernandes R, Cooley K, i in. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review. Integr Cancer Ther. maj 2015;14(3):201–11.
Zhang M, Zhang Y, Zhang L, Tian Q. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Prog Mol Biol Transl Sci. 2019;163:297–328.
Joseph TP, Chanda W, Padhiar AA, Batool S, LiQun S, Zhong M, i in. A Preclinical Evaluation of the Antitumor Activities of Edible and Medicinal Mushrooms: A Molecular Insight. Integr Cancer Ther. czerwiec 2018;17(2):200–9.
Khunoana ET, Nkadimeng SM. Current Advances in the Use of Mushrooms as Therapeutics for Lung Cancer: A Review. Mol Basel Switz. 14 marzec 2025;30(6):1322.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2026 MAGDALENA BODERA, RADOSLAW SZYDLOWSKI, ANNA KAZMIERSKA, ANNA HAMERLA, HANNA PORWOLIK, MAREK SKOTARSKI, JULIA GAWRON, DOMINIK RABSTEIN, PIOTR GOSCINIEWICZ
This work is licensed under a Creative Commons Attribution 4.0 International License.
